TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16732007

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 476

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 476
Study: 15301647

Group type: EXPERIMENTAL
Intervention: Panic Control Therapy (PCT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 80
Study: 11503783

Group type: EXPERIMENTAL
Intervention: Cisplatin + Paclitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin (monotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin + Etoposide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin + Teniposide
Number of subjects: 0
Study: 9071861

Group type: EXPERIMENTAL
Intervention: Iron deficiency intervention
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 320
Study: 8384187

Group type: EXPERIMENTAL
Intervention: ECA (ephedrine 75‐150mg, caffeine 150mg, aspirin 330mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3519551

Group type: EXPERIMENTAL
Intervention: Once-a-week radiation therapy (1 X W) - 6000 rad using 500 rad fractions for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Daily radiation therapy (5 X W) - 6000 rad using 200 rad fractions for 6 weeks
Number of subjects: 100
Study: 30885221

Group type: EXPERIMENTAL
Intervention: Armolipid Plus (AP) - 500 mg berberine, 3 mg monacolin K, 10 mg policosanol, once daily for 24 weeks
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo (PL) - once daily for 24 weeks
Number of subjects: 158
Study: 30141444

Group type: EXPERIMENTAL
Intervention: 200μg of intravaginal misoprostol every 6 hours for up to 48 hours
Number of subjects: 30
Study: 26952037

Group type: EXPERIMENTAL
Intervention: BOW015
Number of subjects: 84

Group type: COMPARATOR
Intervention: rIFX
Number of subjects: 84
Study: 25161155

Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin with 40 mg simvastatin
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 53
Study: 22935476

Group type: EXPERIMENTAL
Intervention: Incredible Years teacher classroom management (TCM) course
Number of subjects: 80

Group type: COMPARATOR
Intervention: Teach as normal (control arm)
Number of subjects: 80
Study: 20445470

Group type: EXPERIMENTAL
Intervention: OP-1 combined with locally available bone from laminectomy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Iliac crest autograft
Number of subjects: 36
Study: 17917927

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 0
Study: 16123873

Group type: EXPERIMENTAL
Intervention: Chitosan pads (Chito‐Seal, Abbott Vascular Devices)
Number of subjects: 80
Study: 14607714

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture therapy (EAT) in combination with liver artery intubation chemotherapy (Group A)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture therapy (EAT) alone (Group B)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Liver artery intubation chemotherapy alone (Group C)
Number of subjects: 106
Study: 10025904

Group type: EXPERIMENTAL
Intervention: Malignant plasma cells from bone marrow and peripheral blood
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Myeloma cells from extramedullary sites (pleural effusion, ascitis, mammary and gastric plasmacytoma)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal non-dividing bone marrow plasma cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highly proliferative reactive plasmacytosis
Number of subjects: 0
Study: 7744151

Group type: EXPERIMENTAL
Intervention: Pyridoxine administration
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 291
Study: 2282207

Group type: EXPERIMENTAL
Intervention: Magnesium supplement
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (normal pregnancies)
Number of subjects: 18
Study: 6786067

Group type: EXPERIMENTAL
Intervention: diltiazem (120 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: diltiazem (240 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo following diltiazem
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: diltiazem
Number of subjects: 12
Study: 31714452

Group type: EXPERIMENTAL
Intervention: Strength training with blood flow restriction (ST-BFR)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Multiple-set training at 30% of 1RM
Number of subjects: 18

Group type: COMPARATOR
Intervention: Multiple-set training at 75% of 1RM
Number of subjects: 18
Study: 30626095

Group type: EXPERIMENTAL
Intervention: 4-day protein restricted diet (0.25 g protein/kg body weight/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Habitual diet (1.3 ± 0.3 g protein/kg body weight/day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Protein restricted diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 16
Study: 28240340

Group type: EXPERIMENTAL
Intervention: ADAPT (adaptation programme)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: ACTIVE (physical activity programme)
Number of subjects: 85
Study: 25391549

Group type: EXPERIMENTAL
Intervention: Hydrocodone ER tablet with low-level coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocodone ER tablet with intermediate-level coating
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocodone ER tablet with high-level coating
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocodone IR/acetaminophen (APAP) 10/325 mg
Number of subjects: 0
Study: 23832726

Group type: EXPERIMENTAL
Intervention: GnRH antagonist group (Group A) - r‐FSH (50‐75 IU/d) plus cetrorelix (0.25 mg/d) starting when ≥ 2 follicles ≥ 14 mm were detected on ultrasound scan.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (Group B) - r‐FSH (50‐75 IU/d) only.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GnRH antagonist group (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 20942865

Group type: EXPERIMENTAL
Intervention: MPT (melphalan 9 mg/m²/d for 4 days every 6 weeks, prednisone 60 mg/m²/d for 4 days every 6 weeks, thalidomide 100 mg/d continuously)
Number of subjects: 122

Group type: COMPARATOR
Intervention: MP (melphalan 9 mg/m²/d for 4 days every 6 weeks, prednisone 60 mg/m²/d for 4 days every 6 weeks)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: MPT
Number of subjects: 122

Group type: COMPARATOR
Intervention: MP
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: MPT and MP
Number of subjects: 122
Study: 19604191

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T(3)) replacement therapy, 20 microg every 12 h starting just before induction of anaesthesia until the first day after surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T(3)) replacement therapy
Number of subjects: 50
Study: 18647466

Group type: EXPERIMENTAL
Intervention: Azithromycin quantitation method using high-performance liquid chromatography coupled to electrospray mass spectrometry
Number of subjects: 0
Study: 16262513

Group type: EXPERIMENTAL
Intervention: Treatment for delinquency and alcohol and/or marijuana use disorders
Number of subjects: 80
Study: 11848168

Group type: EXPERIMENTAL
Intervention: Amlodipine (AML)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Losartan (LOS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Amlodipine (AML) and Losartan (LOS)
Number of subjects: 15
Study: 10077137

Group type: COMPARATOR
Intervention: Fenoterol (1 puff [200 microg/puff] every 1 min for 5 min; total 1000 microg)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Fenoterol plus oxitropium bromide (2 puffs [100 microg/puff] every 1 min for 5 min; total 1000 microg)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Fenoterol plus oxitropium bromide
Number of subjects: 69
Study: 7483800

Group type: EXPERIMENTAL
Intervention: MMR vaccine containing the Urabe mumps strain
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: MMR vaccine containing the Jeryl Lynn mumps strain
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: MMR vaccine containing the Schwarz strain
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: MMR vaccine (all types)
Number of subjects: 475
Study: 2298472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide, Atenolol, Captopril, Zofenopril
Number of subjects: 51
Study: 6113352

Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30981681

Group type: EXPERIMENTAL
Intervention: Diet M - high monounsaturated fat hypocaloric diet
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Diet P - high polyunsaturated fat hypocaloric diet
Number of subjects: 361
Study: 31006262

Group type: EXPERIMENTAL
Intervention: Jet-lavage
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no lavage)
Number of subjects: 40
Study: 30541641

Group type: EXPERIMENTAL
Intervention: Volume Controlled Ventilation (VCV) with 7 L/min atomized oxygen flow
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Pressure Controlled Ventilation (PCV) with 9 L/min atomized oxygen flow
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Simulated scuba test under VCV mode with 9 L/min atomized oxygen flow
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Simulated scuba test under PCV mode with 9 L/min atomized oxygen flow
Number of subjects: 77
Study: 27994300

Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Preconditioning (RIPC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (sham, un-inflated cuff)
Number of subjects: 100
Study: 25551178

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy for impetigo
Number of subjects: 508
Study: 22726916

Group type: EXPERIMENTAL
Intervention: 5 sets of 30 s postero-anterior mobilisations
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 5 sets of 60 s postero-anterior mobilisations
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 5 sets of postero-anterior mobilisations
Number of subjects: 19
Study: 20637445

Group type: EXPERIMENTAL
Intervention: Knowledge sources
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis domain of the HSRT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reasoning skills
Number of subjects: 0
Study: 18468899

Group type: EXPERIMENTAL
Intervention: ACL-deficient patients
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy athletes
Number of subjects: 24
Study: 16575135

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 125 mg twice daily along with macrolides (azitromycin for five days)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group treated only with antibiotics (macrolides)
Number of subjects: 54
Study: 14645774

Group type: EXPERIMENTAL
Intervention: Behavior problem score at age 35 months
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Behavior problems in children with asthma
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Behavior problems as a marker
Number of subjects: 265
Study: 10194656

Group type: EXPERIMENTAL
Intervention: Fosinopril (ACE inhibitor), 12 weeks treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 8946872

Group type: EXPERIMENTAL
Intervention: 5‐FU chemotherapy via pelvic retroperitoneal cannulation
Number of subjects: 25
Study: 1753321

Group type: EXPERIMENTAL
Intervention: Open flap debridement and placement of the synthetic wound dressing over the furcation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Open flap debridement alone
Number of subjects: 19
Study: 6763175

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (Healon)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Balanced salt solution or air
Number of subjects: 40
Study: 31331575

Group type: EXPERIMENTAL
Intervention: Rhythmical Massage (RM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Heart Rate Variability Biofeedback (HRV-BF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both therapies (RM and HRV-BF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Body silhouette diagrams
Number of subjects: 60
Study: 28183140

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study: 26452466

Group type: EXPERIMENTAL
Intervention: Collaborative smoking cessation intervention
Number of subjects: 800

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 800
Study: 23337728

Group type: EXPERIMENTAL
Intervention: Odanacatib 50 mg weekly
Number of subjects: 214
Study: 21266948

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 1801

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1801
Study: 19835115

Group type: EXPERIMENTAL
Intervention: Alternate acupuncture group (opposing needling and non-opposing needling, twice daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine acupuncture group (acupuncture at the affected side, once daily)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Alternate acupuncture group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine acupuncture group
Number of subjects: 80
Study: 17386282

Group type: EXPERIMENTAL
Intervention: Timolol maleate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Brinzolamide
Number of subjects: 24
Study: 15322457

Group type: EXPERIMENTAL
Intervention: PMRP+25
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PMRP+50
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PMRP
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sitting
Number of subjects: 10
Study: 11594943

Group type: EXPERIMENTAL
Intervention: High-dose antioxidant formulation (vitamin C, 500 mg; vitamin E, 400 IU; beta carotene, 15 mg)
Number of subjects: 4629

Group type: COMPARATOR
Intervention: Placebo (no antioxidants)
Number of subjects: 4629
Study: 9692520

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg orally once a day for 3 days
Number of subjects: 34

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg orally every 12 h for 10 days
Number of subjects: 34
Study: 8164925

Group type: EXPERIMENTAL
Intervention: Triphasic DSG/EE
Number of subjects: 812

Group type: COMPARATOR
Intervention: Triphasic NE/EE
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Triphasic DSG/EE and Triphasic NE/EE
Number of subjects: 812
Study: 3211806

Group type: EXPERIMENTAL
Intervention: Orchidectomy (ORX, n = 37)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Combined intramuscular and oral estrogen treatment (ESTR, n = 41)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both treatments (ORX and ESTR)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patients with metastatic disease
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patients with nonmetastatic disease
Number of subjects: 78
Study: 31430623

Group type: EXPERIMENTAL
Intervention: Wi-Fi signal cues in the PIU group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Wi-Fi signal cues under negative affect priming in the PIU group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with neutral cues
Number of subjects: 60
Study: 29090984

Group type: EXPERIMENTAL
Intervention: Ball attachments (group A)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Locator attachments (group B)
Number of subjects: 22
Study: 26129787

Group type: EXPERIMENTAL
Intervention: Anterior mitral isthmus ablation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Posterior mitral isthmus ablation
Number of subjects: 80
Study: 23486236

Group type: EXPERIMENTAL
Intervention: Probiotic lozenges containing L. reuteri (DSM 17938 and ATCC PTA 5289; 1 × 10(8) CFU of each strain), 2/day
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo lozenges lacking lactobacilli
Number of subjects: 62
Study: 21636819

Group type: EXPERIMENTAL
Intervention: Treadmill aerobic exercise training (TM)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control intervention of nonaerobic stretching
Number of subjects: 38
Study: 18768332

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg qd
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg bid
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 1024
Study: 16946431

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser with distilled water irrigation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser with 5.25% NaOCl irrigation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Rotary instrumentation with distilled water irrigation
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Rotary instrumentation with 5.25% NaOCl irrigation
Number of subjects: 72
Study: 15478759

Group type: EXPERIMENTAL
Intervention: Working Memory (WM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second‐order WM factor
Number of subjects: 0
Study: 11306522

Group type: EXPERIMENTAL
Intervention: apoA-I(M) carriers
Number of subjects: 21

Group type: COMPARATOR
Intervention: Hypoalphalipoproteinemia (HA) subjects
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 21

Group type: COMPARATOR
Intervention: HA subjects
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Echocardiographic findings and maximal treadmill ECG
Number of subjects: 21
Study: 9141257

Group type: EXPERIMENTAL
Intervention: Sponging alone
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Aspirin 15 mg/kg
Number of subjects: 224

Group type: COMPARATOR
Intervention: Paracetamol 15 mg/kg
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Ibuprofen 8 mg/kg
Number of subjects: 224

Group type: COMPARATOR
Intervention: Tepid water sponging
Number of subjects: 224
Study: 8186346

Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate one tablet q.d.s
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ranitidine 150 mg b.d.
Number of subjects: 14
Study: 3035166

Group type: EXPERIMENTAL
Intervention: Salt and peroxide oral hygiene regimen
Number of subjects: 231

Group type: COMPARATOR
Intervention: Conventional oral hygiene regimen
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 231
Study: 29797912

Group type: EXPERIMENTAL
Intervention: Paraplegic triple needling combined with rehabilitation training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional needling combined with rehabilitation training
Number of subjects: 50
Study: 26321112

Group type: EXPERIMENTAL
Intervention: Single-Bundle ACL Reconstruction
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Double-Bundle ACL Reconstruction
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 64
Study: 25429853

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Vitamin E 800 IU
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: NASH resolution
Number of subjects: 222
Study: 23419093

Group type: EXPERIMENTAL
Intervention: Keratinocyte growth factor (palifermin, 60 μg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride solution)
Number of subjects: 0
Study: 20544030

Group type: EXPERIMENTAL
Intervention: Clinician-assisted treatment
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Technician-assisted treatment
Number of subjects: 141

Group type: COMPARATOR
Intervention: Delayed treatment (control group)
Number of subjects: 141
Study: 19301502

Group type: EXPERIMENTAL
Intervention: Early sexual initiation among boys (34.9%)
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Early sexual initiation among girls (20.6%)
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Risk factors for boys
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Risk factors for girls
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Multiple sexual partners among boys (37.3%)
Number of subjects: 1514

Group type: EXPERIMENTAL
Intervention: Multiple sexual partners among girls (12.9%)
Number of subjects: 1514
Study: 16631431

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate solution (n=8)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 6-g essential amino acid mixture (n=8)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combined carbohydrate and essential amino acid supplement (n=8)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo beverage (n=8)
Number of subjects: 32
Study: 12812357

Group type: EXPERIMENTAL
Intervention: mefloquine-artesunate
Number of subjects: 0

Group type: COMPARATOR
Intervention: mefloquine-primaquine
Number of subjects: 0
Study: 11553245

Group type: EXPERIMENTAL
Intervention: Forced air warming
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional blankets without active warming (Control)
Number of subjects: 59
Study: 9553683

Group type: EXPERIMENTAL
Intervention: Controfilina-200 (test preparation)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Reference preparation
Number of subjects: 12
Study: 7998664

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 106

Group type: COMPARATOR
Intervention: Terfenadine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 3189898

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.3 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 1 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 2.5 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 33
Study: 30027669

Group type: EXPERIMENTAL
Intervention: Sickle cell disease cohort with SNP genotyping
Number of subjects: 2795

Group type: EXPERIMENTAL
Intervention: Sickle cell disease cohort
Number of subjects: 2795